Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up

Documenti analoghi

• The new assay type IV collagen 7S (CLEIA) is a useful test to identify progressive fibrosis in chronic liver disease: A study based on magnetic resonance elastography
  di: Miwa Kawanaka, et al.
  Pubblicazione: (2025)
• Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis‐3 index
  di: Kazuya Kariyama, et al.
  Pubblicazione: (2024)
• Metronidazole‐induced encephalopathy after living donor liver transplantation
  di: Kazuhiro Takahashi, et al.
  Pubblicazione: (2024)
• Alcohol Intake and Cardiometabolic Risk Factors Are Independently Associated With a Higher AST/Platelet Ratio Index in Obese Males
  di: Hideki Fujii, et al.
  Pubblicazione: (2025)
• Characteristics of diabetes mellitus patients with nonviral chronic liver disease who developed hepatocellular carcinoma
  di: Kyo Sasaki, et al.
  Pubblicazione: (2024)